Valuation: InterCure Ltd.

Market Cap 178M 0 158M 147M 133M 252M 16.89B 256M 1.76B 691M 8.81B 668M 654M 28.09B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 314M 0 279M 259M 236M 445M 29.83B 452M 3.11B 1.22B 15.56B 1.18B 1.15B 49.62B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
61.79%
Yield 2024 *
-
Yield 2025 -
1 day-5.39%
1 week-9.61%
Current month-15.27%
1 month-13.41%
3 months-1.69%
6 months+23.89%
Current year-12.18%
1 week 1,421
Extreme 1421
1,599
1 month 1,421
Extreme 1421
1,701
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,621
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 67 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 A Other

Chief Financial Officer

539,947 0.9874%
3/18/26 A Other

Director

19,046 0.0348%
3/18/26 A Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-5.39%-9.61%-44.73%-41.53% 57.37M
-0.24%+7.20%+11.92%+29.92% 118B
-2.06%+1.72%+7.67%+89.20% 99.34B
-2.80%-1.81%+116.54%+839.45% 56.71B
-0.72%+6.42%-5.38%+81.83% 28.56B
-1.74%+1.74%+24.00%+91.38% 25.94B
-2.19%+1.86%+11.19%+57.60% 25.79B
-2.86%+1.32%+33.62%+379.54% 21.52B
-0.59%-2.26%-21.00%-4.17% 20.7B
-0.65%-6.95%+4.36%+88.03% 18.25B
Average -1.94%+0.03%+13.82%+161.12% 41.5B
Weighted average by Cap. -1.45%+2.42%+23.86%+182.85%

Financials

2024 2025
Net sales 239M 0 212M 197M 179M 338M 22.67B 343M 2.37B 927M 11.83B 896M 877M 37.71B 270M 0 240M 223M 203M 382M 25.64B 388M 2.68B 1.05B 13.38B 1.01B 992M 42.66B
Net income -67.8M -0 -60.26M -55.86M -50.82M -95.9M -6.43B -97.43M -671M -263M -3.36B -254M -249M -10.7B -35.71M -0 -31.74M -29.42M -26.77M -50.51M -3.39B -51.32M -354M -139M -1.77B -134M -131M -5.64B
Net Debt 133M 0 118M 109M 99.51M 188M 12.6B 191M 1.31B 515M 6.57B 498M 488M 20.96B 136M 0 121M 112M 102M 193M 12.94B 196M 1.35B 529M 6.75B 512M 501M 21.53B
Projected Income Statement - Annual - InterCure Ltd.
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
19/10/26 ILA 1,418.00 -5.59% 10,019
16/10/26 ILA 1,502.00 +0.74% 8,457
15/10/26 ILA 1,491.00 -1.19% 2,779
14/10/26 ILA 1,509.00 -1.69% 4,374
13/10/26 ILA 1,535.00 -2.35% 4,916
  1. Stock Market
  2. Stocks
  3. INCR Stock